Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ - Fiorentino, D F; Chung, L S; Christopher-Stine, L (Arthritis Rheum, 2013)
, et al.